Avista Pharma Solutions, Inc. dba Cambrex
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 3501 Tricenter Blvd Ste C, Durham, North Carolina (NC) 27713-1868, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3011795391 · DUNS 108353231
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-07-03
- NAIDrug Quality Assurance2020-07-17
- NAIDrug Quality Assurance2012-10-30
- NAIDrug Quality Assurance2009-10-09
Drugs this plant is listed as making
2 distinct drugs across 7 products name this site in their FDA label.
- Berotralstat hydrochlorideBioCryst Pharmaceuticals, Inc.
- Sodium ThiosulfateFennec Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.